Fluicell Ab Stock Fundamentals
| FLUI Stock | SEK 0.04 0.0008 1.98% |
Fluicell AB fundamentals help investors to digest information that contributes to Fluicell's financial success or failures. It also enables traders to predict the movement of Fluicell Stock. The fundamental analysis module provides a way to measure Fluicell's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fluicell stock.
Fluicell |
Fluicell AB Company Operating Margin Analysis
Fluicell's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Fluicell Operating Margin | (8.62) % |
Most of Fluicell's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fluicell AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Fluicell AB has an Operating Margin of -8.6166%. This is 75.44% lower than that of the Healthcare sector and 92.31% lower than that of the Biotechnology industry. The operating margin for all Sweden stocks is 56.38% higher than that of the company.
Fluicell AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Fluicell's current stock value. Our valuation model uses many indicators to compare Fluicell value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Fluicell competition to find correlations between indicators driving Fluicell's intrinsic value. More Info.Fluicell AB is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Fluicell's earnings, one of the primary drivers of an investment's value.Fluicell Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fluicell's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Fluicell could also be used in its relative valuation, which is a method of valuing Fluicell by comparing valuation metrics of similar companies.Fluicell is currently under evaluation in operating margin category among its peers.
Fluicell Fundamentals
| Return On Equity | -1.13 | |||
| Return On Asset | -0.49 | |||
| Operating Margin | (8.62) % | |||
| Current Valuation | 49.13 M | |||
| Shares Outstanding | 24.49 M | |||
| Shares Owned By Insiders | 11.20 % | |||
| Shares Owned By Institutions | 0.67 % | |||
| Price To Book | 4.86 X | |||
| Price To Sales | 10.51 X | |||
| Revenue | 2.6 M | |||
| Gross Profit | 1.89 M | |||
| EBITDA | (21.08 M) | |||
| Net Income | (21.69 M) | |||
| Cash And Equivalents | 20.69 M | |||
| Cash Per Share | 1.45 X | |||
| Debt To Equity | 0.19 % | |||
| Current Ratio | 2.30 X | |||
| Book Value Per Share | 0.76 X | |||
| Cash Flow From Operations | (18.64 M) | |||
| Earnings Per Share | (1.68) X | |||
| Number Of Employees | 19 | |||
| Beta | 1.96 | |||
| Market Capitalization | 73.64 M | |||
| Total Asset | 26.98 M | |||
| Net Asset | 26.98 M |
About Fluicell Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fluicell AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fluicell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fluicell AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Fluicell AB provides single-cell discovery platforms for biomedicine, drug development, and bioprinting applications worldwide. The company was founded in 2012 and is based in Gothenburg, Sweden. Fluicell operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 17 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fluicell Stock Analysis
When running Fluicell's price analysis, check to measure Fluicell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fluicell is operating at the current time. Most of Fluicell's value examination focuses on studying past and present price action to predict the probability of Fluicell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fluicell's price. Additionally, you may evaluate how the addition of Fluicell to your portfolios can decrease your overall portfolio volatility.